Articles | Open Access | https://doi.org/10.55640/

OPTIMIZATION OF INDIVIDUAL DOSING OF CARDIOTROPIC DRUGS TO IMPROVE CARDIAC CONTRACTILE FUNCTION

Jalolov Bakhtiyar Bakhodirovich , Assistant, Departmentof Hospital Pediatrics Andijan State Medical Institute, Uzbekistan

Abstract

Acute and chronic heart failure are characterized by impaired cardiac contractile function (inotropy), leading to reduced cardiac output and end-organ hypoperfusion. Cardiotropic drugs, particularly inotropes, are a cornerstone of treatment in acute decompensated heart failure and cardiogenic shock, designed to directly enhance myocardial contractility. However, these agents possess a narrow therapeutic window and are associated with significant risks, including arrhythmogenesis, increased myocardial oxygen consumption, and potential long-term cardiotoxicity. A standardized, "one-size-fits-all" dosing approach fails to account for the vast inter-patient variability in pathophysiology, comorbidities, and pharmacodynamic response. Therefore, optimizing the individual dosage of these potent medications is a critical clinical challenge. This article explores the modern strategies for personalizing inotrope therapy, aiming to maximize hemodynamic benefits while minimizing adverse effects, thereby improving patient outcomes.

Keywords

inotropes, heart failure, cardiac contractility, personalized medicine, hemodynamic monitoring, dose optimization, dobutamine, milrinone, cardiogenic shock.

References

Beaubien-Souligny, W., Rola, P., Haycock, K., Bouchard, J., Lamarche, Y., Spiegel, R., & Denault, A. Y. (2020). Quantifying systemic congestion with point-of-care ultrasound: development of the venous excess ultrasound grading system. The Ultrasound Journal, 12(1), 16. https://doi.org/10.1186/s13089-020-00163-w

Francis, G. S., Bartos, J. A., & Adatya, S. (2021). Inotropes. Journal of the American College of Cardiology, 77(12), 1547–1560. https://doi.org/10.1016/j.jacc.2021.01.053

Guglin, M. (2017). Inotropes in heart failure: The good, the bad, and the ugly. Current Heart Failure Reports, 14(6), 481–484. https://doi.org/10.1007/s11897-017-0361-9

Liggett, S. B. (2013). β-Adrenergic receptor pharmacogenomics. Pharmacology & Therapeutics, 138(3), 448–460. https://doi.org/10.1016/j.pharmthera.2013.02.008

Tehrani, B. N., Truesdell, A. G., Sherwood, M. W., Desai, S., Tran, H. A., Epps, K. C., Singh, R., & Katz, S. (2014). Standardized team-based care for cardiogenic shock. Journal of the American College of Cardiology, 63(16), 1659–1660. https://doi.org/10.1016/j.jacc.2014.01.037

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

OPTIMIZATION OF INDIVIDUAL DOSING OF CARDIOTROPIC DRUGS TO IMPROVE CARDIAC CONTRACTILE FUNCTION. (2025). International Journal of Medical Sciences, 5(10), 93-98. https://doi.org/10.55640/